Phenomix Sciences Releases Survey Findings on Patient Awareness of Obesity Treatment Options
Report examines views on GLP-1 medications, alternative therapies, and the role of patient education in treatment decisions Phenomix Sciences…
Report examines views on GLP-1 medications, alternative therapies, and the role of patient education in treatment decisions Phenomix Sciences…
Deal adds Northeast-based clinical denials expertise and post-bill DRG validation to EnableComp’s complex revenue cycle offerings EnableComp intends to…
Respondents also reported difficulty paying medical bills and expressed interest in easier payment options, including financing offered through care…
Doceree360 report outlines six transformative shifts that will redefine pharmaceutical marketing by 2027 Doceree, the AI-powered operating system for…
National poll finds access barriers and wait times driving interest in virtual dermatology care Nov. 18, 2025 — Miiskin…
Toronto, ON — NuraLogix, a company developing contactless health insight technology, has introduced a new multi-year cardiovascular disease (CVD)…
A large population-based Korean study has found that patients with type 2 diabetes starting on SGLT2 inhibitors had a…